Analystreport

Axsome Therapeutics Inc (NASDAQ: AXSM) had its price target raised by analysts at SunTrust Banks, Inc. to $60.00. They now have a "positive" rating on the stock.

Axsome Therapeutics, Inc.  (AXSM) 
Last axsome therapeutics, inc. earnings: 3/12 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: axsome.com